AstraZeneca’s Crestor cuts deaths and heart attacks

NEW ORLEANS (Reuters) - AstraZeneca's cholesterol fighter Crestor dramatically cut deaths, heart attacks and strokes in patients with healthy cholesterol levels but who had high levels of a protein

associated with heart disease, researchers said on Sunday.

No related posts.